Amgen Inc.
AMGNFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
33,424
Cost of Revenue
12,858
Gross Profit
20,566
Gross Margin
61.5%
Operating Income
7,258
Operating Margin
21.7%
Net Income
4,090
Net Margin
12.2%
EPS (Basic)
$7.62
EPS (Diluted)
$7.56
EBITDA
13,356
EBITDA Margin
40.0%
2023
12/31/2023
Revenue
28,190
Cost of Revenue
8,415
Gross Profit
19,775
Gross Margin
70.1%
Operating Income
7,897
Operating Margin
28.0%
Net Income
6,717
Net Margin
23.8%
EPS (Basic)
$12.56
EPS (Diluted)
$12.49
EBITDA
14,801
EBITDA Margin
52.5%
2022
12/31/2022
Revenue
26,323
Cost of Revenue
6,406
Gross Profit
19,917
Gross Margin
75.7%
Operating Income
9,566
Operating Margin
36.3%
Net Income
6,552
Net Margin
24.9%
EPS (Basic)
$12.18
EPS (Diluted)
$12.11
EBITDA
12,169
EBITDA Margin
46.2%
2021
12/31/2021
Revenue
25,979
Cost of Revenue
6,454
Gross Profit
19,525
Gross Margin
75.2%
Operating Income
7,639
Operating Margin
29.4%
Net Income
5,893
Net Margin
22.7%
EPS (Basic)
$10.34
EPS (Diluted)
$10.28
EBITDA
11,296
EBITDA Margin
43.5%
2020
12/31/2020
Revenue
25,424
Cost of Revenue
6,159
Gross Profit
19,265
Gross Margin
75.8%
Operating Income
9,139
Operating Margin
35.9%
Net Income
7,264
Net Margin
28.6%
EPS (Basic)
$12.40
EPS (Diluted)
$12.31
EBITDA
12,996
EBITDA Margin
51.1%